Biz Misled On Gene Therapy Toxicity Pre-IPO, Investors Say – Law360
|
Biz Misled On Gene Therapy Toxicity Pre-IPO, Investors Say
Law360 Biz Misled On Gene Therapy Toxicity Pre-IPO, Investors Say. By Cara Bayles. Law360 (March 28, 2018, 4:54 PM EDT) — Solid Biosciences Inc. has been accused of securities fraud in a Massachusetts federal lawsuit filed Tuesday by a putative class of … |
